Orchid Ventures, Inc.: Orchid Ventures Announces Financial Results for Period Ended March 31, 2021
/ ORCHID VENTURES, INC. (CSE:ORCD; OTC:ORVRD) (the
Company or
Orchid ) is pleased to announce its third quarter ( Q3 2021 ) financial results for the period ended March 31, 2021. All amounts expressed are in United States dollars.
Nine Months Ended March 31, 2021
Nine Months Ended March 31, 2020
Variance
$(994,357)
-77%
Financial statements are prepared in accordance with International Financial Reporting Standards (IFRS). Detailed information regarding the Company s financial results as well as management s discussion and analysis can be found on its SEDAR profile at https://sedar.com/ and https://ir.orchidessentials.com/.
Management Commentary
Orchid Ventures Announces Financial Results for Period Ended March 31, 2021 pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Flower One Announces Modification to Loan Agreement and Issues Warrants to its Lender per the Loan Modification and Amendment Agreement
May 8, 2021 GMT
Flower One Holdings Inc. (“
Flower One ” or the “
Company ”) (CSE: FONE) (OTCQX: FLOOF) (FSE: F11), the leading cannabis cultivator and producer in Nevada, announced today that it has modified and amended certain terms of its loan agreement dated August 21, 2020 (the “
Loan Agreement ”) pursuant to a modification and amendment loan agreement dated March 8, 2021 among Gold Flora LLC, a California limited liability company (the “
Flower One Holdings Inc.: Flower One Announces Modification to Loan Agreement and Issues Warrants to its Lender per the Loan Modification and Amendment Agreement
Flower One or the
Company ) (CSE: FONE) (OTCQX: FLOOF) (FSE: F11), the leading cannabis cultivator and producer in Nevada, announced today that it has modified and amended certain terms of its loan agreement dated August 21, 2020 (the
Loan Agreement ) pursuant to a modification and amendment loan agreement dated March 8, 2021 among Gold Flora LLC, a California limited liability company (the
Lender ), CN Landco, LLC, a Nevada limited liability company (the
Borrower ) and the Company (the
Loan Modification and Amendment Agreement
On Monday,
Tilray, Inc. (NASDAQ:TLRY) and
Aphria, Inc. (NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a combined market cap of $3.3 billion. Benzinga spoke with
Irwin Simon, CEO of the new combined company.
Check out the video below:
Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23.
Jazz Pharmaceuticals (NASDAQ:JAZZ) finalized its acquisition of
GW Pharmaceuticals plc. (NASDAQ:GWPH), the producer of the FDA‑approved prescription cannabidiol drug Epidiolex, for $7.2 billion or $6.7 billion net of GW Pharma s cash.
Meanwhile,
Ascend Wellness Holdings (CSE:AAWH) started trading on the Canadian Securities exchange following a raise of approximately $80 million through an initial public offering of roughly 10 million shares of its Class A common stock at $8 per share.